Low OIP5-AS1 expression increases miR-367-3p expression, thereby decreasing CEBPA, which facilitates glioma development by binding to the promoter of TRAF4 (which promotes cancer proliferation, migration, and invasion and inhibits apoptosis), ultimately weakening TRAF4 expression. The gene discussed is OIP5; the disease is central nervous system cancer.